Author Archives: acqiadmin1

A/Prof Megan Hyun from the University of Nebraska Medical Center will be presenting a talk on “Ethical Considerations for Artificial Intelligence in Radiology and Radiation Oncology”. This topic is of considerable relevance to the work of ACQI. The webinar can be accessed from here.

ACQI researchers are very grateful to receive an injection of support from the RPH (Royal Perth Hospital) Imaging Research Fund. The Round #3 Research Grant will provide $79,766 to support a new study into the use of amide proton transfer magnetic resonance imaging (APT MRI) for characterising the extent and nature of glioblastoma, and forContinue reading “Generous support from RPH Imaging Research Fund”

We welcome Malik Ghafoor to the ACQI team as the new Manager of Computing Infrastructure. Malik has a degree in Electrical Engineering and Master of Data Science and brings several years of experience in data engineering to the team. Malik will help to develop our systems for data acquisition during national multicentre clinical trials, forContinue reading “Malik joins the ACQI team”

ACQI Research Fellow Dr Mikaela Dell’Oro has been awarded the Dr. Udupi Madhvanath Memorial AFOMP Best PhD Award in Radiobiology, 2022, by the Asia-Oceania Federation of Organisations for Medical Physics (AFOMP). This award recognises the excellence of Mikaela’s PhD work, undertaken at the University of South Australia, which involved assessing the potential radiobiological impact andContinue reading “ACQI researcher’s achievements recognised by international medical physics organisation”

ACQI researcher Mikaela Dell’Oro has visited the international headquarters of ACQI partner AIQ Solutions in Madison Wisconsin, to review progress and strategy for translation of results from cancer imaging studies to clinical use. Mikaela is shown second from left together with ACQI-based AIQ AI engineer Shasha Yeung, fifth from left. This pivotal partnership with AIQContinue reading “Strengthening ties with industry – ACQI and AIQ Solutions”

ACQI and UWA Medical Physics Group PhD student Jake Kendrick has just published the results of his study into automated detection and segmentation of prostate cancer metastases in PSMA PET images. Jake collaborated with a team of physicists, computer scientists and nuclear medicine specialists to use deep learning to replicate the image assessment of anContinue reading “ACQI all-star Jake publishes new study on AI applications in advanced prostate cancer”

ACQI Co-Director, Prof Martin Ebert, has just completed a three month Fulbright Future Scholar fellowship at the University of Wisconsin (Madison). Prof Ebert worked with the tumour tracking group led by Prof Robert Jeraj, which researchers the use of medical imaging for following the response of advanced cancers to therapy, aiding treatment decision making andContinue reading “ACQI Co-Director wraps up Fulbright visit to University of Wisconsin, Madison USA”

ACQI, via the University of Western Australia, and AIQ Solutions, have formally agreed to work on collaborative research to investigate the applications of the software solutions developed by AIQ. AIQ are a startup out of Madison Wisconsin, developing methods for tracking the response of cancers and other diseases with quantitative imaging.

As part of ACQI’s collaboration with AIQ Solutions, we are very please to welcome Mikaela Dell’Oro as a new Research Associate. Mikaela joins us from Adelaide where she undertook her PhD at the University of South Australia studying the potential long term effects of treatment of childhood cancers with radiotherapy. Mikaela brings unique skills inContinue reading “Mikaela joins the ACQI team to accelerate translational molecular imaging in oncology”

ACQI-affiliated PhD candidate Jake Kendrick has published a review of studies that have examined methods for predicting the outcomes of treatment for metastatic prostate cancer using imaging. This rapidly-evolving field is offering to facilitate patient-specific prognosis, the ability to intervene earlier as disease progresses and the opportunity to make patient care more cost effective.